# Antidepressant-Like Effects of n-Butylidenephthalide Using In Vivo and In Silico Approaches

**Authors:** María Leonor González-Rivera, María del Carmen Juárez-Vázquez, Athzirys Alejandra Melecio-Hernández, Diana Casique-Aguirre, Gabriela Josefina López-González, Ramsés Maximiliano Ramírez-Martínez, Andrea Ayala-Torres, Yurisleidys Quesada-Mendiola, Juan Ramón Zapata-Morales, Angel Josabad Alonso-Castro

PMC · DOI: 10.3390/ph19020242 · 2026-01-30

## TL;DR

The compound n-butylidenephthalide (BP) shows antidepressant-like effects in mice, possibly through serotonergic and adrenergic systems.

## Contribution

BP's antidepressant-like effects and potential mechanism of action are explored using both in vivo and in silico methods.

## Key findings

- BP showed antidepressant-like effects comparable to amitriptyline in acute assays.
- Serotonergic and adrenergic systems are involved in BP's antidepressant-like effects.
- BP had limited effects in a chronic reserpine-induced depression model compared to amitriptyline.

## Abstract

Background: The plant-derived compound n-butylidenephthalide (BP) is an isobenzofuranone that has shown neuropharmacological effects on preclinical models of Parkinson’s, Alzheimer’s, and amyotrophic lateral sclerosis. Methods: This study evaluated the anti-inflammatory, antinociceptive, anxiolytic-like, hypnotic, anticonvulsant, and antidepressant-like effects of BP (50–200 mg/kg p.o.) using Balb/c mice in acute assays. This study also evaluated the antidepressant-like effects of BP in a mouse model of reserpine-induced depression-like behavior for 20 days. Inhibitors involved in the molecular process of depression and in silico studies were used to evaluate a possible mechanism of action for the antidepressant-like effects of BP. Results: BP induced low anti-inflammatory effects, showed low anticonvulsant effects, and lacked hypnotic effects or motor impairment in acute assays. The antidepressant-like effects of BP (100–200 mg/kg p.o.) were comparable to amitriptyline (25 mg/kg p.o.) in acute assays. The participation of serotonergic and adrenergic systems is involved in the acute antidepressant-like effects of BP. In the reserpine-induced depression model, BP (100 mg/kg p.o.) showed antidepressant-like effects in one of the two antidepressant tests, but with a lower effect than amitriptyline (20 mg/kg p.o.). Conclusions: BP (100 and 200 mg/kg) showed antidepressant-like effects in acute assays and, to a lesser extent, in a reserpine-induced chronic model of depression-like behavior.

## Linked entities

- **Chemicals:** n-butylidenephthalide (PubChem CID 5352899), amitriptyline (PubChem CID 2160), reserpine (PubChem CID 5770)
- **Diseases:** amyotrophic lateral sclerosis (MONDO:0004976), depression (MONDO:0002050)

## Full-text entities

- **Genes:** ABCB1 (ATP binding cassette subfamily B member 1) [NCBI Gene 5243] {aka ABC20, CD243, CLCS, ENPAT, GP170, MDR1}, CYP2C9 (cytochrome P450 family 2 subfamily C member 9) [NCBI Gene 1559] {aka CPC9, CYP2C, CYP2C10, CYPIIC9, P450-2C9, P450IIC9}, CYP1A2 (cytochrome P450 family 1 subfamily A member 2) [NCBI Gene 1544] {aka CP12, CYPIA2, P3-450, P450(PA)}, Nos2 (nitric oxide synthase 2, inducible) [NCBI Gene 18126] {aka MAC-NOS, NOS-II, Nos-2, Nos2a, i-NOS, iNOS}, Ccl6 (C-C motif chemokine ligand 6) [NCBI Gene 20305] {aka MRP-1, Scya6, c10}, IL6 (interleukin 6) [NCBI Gene 3569] {aka BSF-2, BSF2, CDF, HGF, HSF, IFN-beta-2}, Tnf (tumor necrosis factor) [NCBI Gene 21926] {aka DIF, TNF-a, TNF-alpha, TNFSF2, TNFalpha, Tnfa}, ATXN3 (ataxin 3) [NCBI Gene 4287] {aka AT3, ATX3, JOS, MJD, MJD1, SCA3}, Mpo (myeloperoxidase) [NCBI Gene 17523] {aka mKIAA4033}, Adra1d (adrenergic receptor, alpha 1d) [NCBI Gene 11550] {aka Adra-1, Adra1, Adra1a, Gpcr8, Spr8, [a]1d}, Fdxr (ferredoxin reductase) [NCBI Gene 14149] {aka AR}, PGP (phosphoglycolate phosphatase) [NCBI Gene 283871] {aka AUM, G3PP, PGPase}, Htr2a (5-hydroxytryptamine (serotonin) receptor 2A) [NCBI Gene 15558] {aka 5-HT-2, 5-HT-2A, E030013E04, Htr-2, Htr2}, Il6 (interleukin 6) [NCBI Gene 16193] {aka Il-6}, CYP2C8 (cytochrome P450 family 2 subfamily C member 8) [NCBI Gene 1558] {aka CPC8, CYP2C8DM, CYPIIC8, MP-12/MP-20}, SNCA (synuclein alpha) [NCBI Gene 6622] {aka NACP, PARK1, PARK4, PD1}, Amt (aminomethyltransferase) [NCBI Gene 434437] {aka EG434437, GCVT}, KCNH2 (potassium voltage-gated channel subfamily H member 2) [NCBI Gene 3757] {aka ERG-1, ERG1, H-ERG, HERG, HERG1, Kv11.1}, CYP2C19 (cytochrome P450 family 2 subfamily C member 19) [NCBI Gene 1557] {aka CPCJ, CYP2C, CYPIIC17, CYPIIC19, P450C2C, P450IIC19}, Gdf5 (growth differentiation factor 5) [NCBI Gene 14563] {aka BMP-14, Cdmp-1, bp, brp}, Slc18a2 (solute carrier family 18 (vesicular monoamine), member 2) [NCBI Gene 214084] {aka 1110037L13Rik, 9330105E13, Vmat2}, Pln (phospholamban) [NCBI Gene 18821] {aka Plb}, Pparg (peroxisome proliferator activated receptor gamma) [NCBI Gene 19016] {aka Nr1c3, PPAR-gamma, PPAR-gamma2, PPARgamma, PPARgamma2}, Il1b (interleukin 1 beta) [NCBI Gene 16176] {aka IL-1beta, Il-1b}, TNF (tumor necrosis factor) [NCBI Gene 7124] {aka DIF, IMD127, TNF-alpha, TNFA, TNFSF2, TNLG1F}
- **Diseases:** epidermal hyperplasia (MESH:D006965), synaptic dysfunction (MESH:C536122), tissue damage (MESH:D017695), neuropathy (MESH:D009422), cognitive dysfunction (MESH:D003072), Depression (MESH:D003866), spinocerebellar ataxia type 3 (MESH:D017827), dopaminergic neuron degeneration (MESH:D009410), constipation (MESH:D003248), involuntary movements (MESH:D020820), Parkinsonism (MESH:D010302), dementia (MESH:D003704), amyloid (MESH:C000718787), drug-induced liver injury (MESH:D056486), PDD (MESH:D019263), dizziness (MESH:D004244), lethargy (MESH:D053609), central nervous system depression (MESH:D016543), weight loss (MESH:D015431), Toxicity (MESH:D064420), amyotrophic lateral sclerosis (MESH:D000690), spasms (MESH:D013035), carcinogenicity (MESH:D011230), deaths (MESH:D003643), hypertension (MESH:D006973), Seizure (MESH:D012640), MDD (MESH:D003865), cardiotoxicity (MESH:D066126), neurofibrillary tangles (MESH:D055956), neurological diseases (MESH:D020271), weight gain (MESH:D015430), ECT (MESH:D013736), Ear Edema (MESH:D004427), mental disorders (MESH:D001523), AD (MESH:D000544), hippocampal atrophy (MESH:D001284), anxiety (MESH:D001007), edema (MESH:D004487), anorexia (MESH:D000855), Inflammation (MESH:D007249), headache (MESH:D006261), injury to (MESH:D014947), neurodegenerative diseases (MESH:D019636), skin (MESH:D012871), Parkinson's (MESH:D010300), anhedonia (MESH:D059445), pain (MESH:D010146), sleep problems (MESH:D012893)
- **Chemicals:** Hydrogen (MESH:D006859), tramadol (MESH:D014147), alcohol (MESH:D000438), Tween 20 (MESH:D011136), dopamine (MESH:D004298), calcium (MESH:D002118), DMSO (MESH:D004121), Formalin (MESH:D005557), serotonin (MESH:D012701), CO2 (MESH:D002245), glutathione (MESH:D005978), fluoxetine (MESH:D005473), Ketanserin (MESH:D007650), cysteine (MESH:D003545), lactone (MESH:D007783), LPS (MESH:D008070), amitriptyline (MESH:D000639), chloroform (MESH:D002725), BP (MESH:C026105), IND (MESH:D007213), amino acid (MESH:D000596), nitrite (MESH:D009573), thiol (MESH:D013438), catecholamines (MESH:D002395), acetone (MESH:D000096), malondialdehyde (MESH:D008315), L-arginine (MESH:D001120), donepezil (MESH:D000077265), CNZ-Clonazepam (-), PTZ (MESH:D010433), glutamate (MESH:D018698), GABA (MESH:D005680), noradrenaline (MESH:D009638), chloride (MESH:D002712), NO (MESH:D009569), ethanol (MESH:D000431), Water (MESH:D014867), 12-O-tetradecanoylphorbol-13-acetate (MESH:D013755), prostaglandins (MESH:D011453), CNZ (MESH:D002998), sodium nitrite (MESH:D012977), Pentobarbital (MESH:D010424), prazosin (MESH:D011224), saline (MESH:D012965), histamine (MESH:D006632), RES (MESH:D012110), oxygen (MESH:D010100)
- **Species:** Pterocyclus angelicoides (species) [taxon 584762], Rattus norvegicus (brown rat, species) [taxon 10116], Homo sapiens (human, species) [taxon 9606], C. elegans [taxon 328850], Ligusticum jeholense (species) [taxon 49553], Angelica sinensis (Chinese angelica, species) [taxon 165353], Mus musculus (house mouse, species) [taxon 10090], Stanhopea tigrina (species) [taxon 125184]
- **Cell lines:** DC2.4 — Mus musculus (Mouse), Transformed cell line (CVCL_J409), C57BL/6 — Mus musculus (Mouse), Transformed cell line (CVCL_C0MU), HEK293 — Homo sapiens (Human), Transformed cell line (CVCL_0045), Balb/c — Mus musculus (Mouse), Spontaneously immortalized cell line (CVCL_0184), Caco-2 — Homo sapiens (Human), Colon adenocarcinoma, Cancer cell line (CVCL_0025), MDCK — Canis lupus familiaris (Dog), Spontaneously immortalized cell line (CVCL_0422), A549 — Homo sapiens (Human), Lung adenocarcinoma, Cancer cell line (CVCL_0023), RPMI-8226 — Homo sapiens (Human), Plasma cell myeloma, Cancer cell line (CVCL_0014)

## Figures

12 figures with captions in the complete paper: https://tomesphere.com/paper/PMC12943633/full.md

---
Source: https://tomesphere.com/paper/PMC12943633